Boots Prepares for Potential London Stock Exchange Listing
The owners of Boots have engaged advisors to position the high street chemist for a potential Initial Public Offering (IPO) in London, which could occur as early as next year. This move signals a significant development for the retail sector and the financial markets.
Private Equity Firm Explores Floating Options
Sycamore Partners, the private equity firm that owns Boots, has been in discussions with advisers in recent weeks regarding the possibility of listing the company on the London Stock Exchange. These talks, initially reported by Reuters, are still in the preliminary stages but represent a strategic effort to capitalize on Boots' recent financial turnaround.
A London IPO would offer a major boost for the London Stock Exchange, as policymakers aim to address a recent decline in listings by implementing more favorable tax and regulatory measures. This potential listing could position London favorably against competing financial hubs such as Amsterdam and New York.
Boots Experiences Profit Rebound
Boots has demonstrated a remarkable profit recovery in recent years, following the closure of several underperforming branches. The firm's pre-tax profit surged nearly sevenfold in the year ending August 2025, reaching £215 million, up from £31 million the previous year. Additionally, revenue and gross profit increased by three percent to £192 million.
Advisors are also being consulted on strategies to expand Boots' presence in the growing beauty and wellness markets. However, it has been reported that Sycamore Partners might reconsider the IPO route and opt to sell Boots instead, depending on market conditions and strategic objectives.
Historical Context and Market Position
Founded in 1849 as a family herbal medicine shop in Nottingham, Boots has a long-standing history in the UK retail landscape. The company was previously listed in London as part of Alliance Boots but became the first FTSE 100 company to be acquired by a private equity firm in 2007.
In 2012, American pharmacy Walgreens acquired a 45 percent stake in Boots, later integrating it into the Walgreens Boots Alliance. Last year, Sycamore Partners purchased the British chemist for $10 billion and established it as a standalone business, setting the stage for potential public listing.
Growing Interest in UK IPOs
Boots would join bookselling giant Waterstones as one of the most anticipated upcoming IPOs in London. Waterstones has accelerated its plans to list in the UK in recent months, appointing Rothschild to advise on the float and reportedly seeking a chairman to lead the process.
Owned by activist investor firm Elliott Management, Waterstones has expanded rapidly under the leadership of James Daunt, acquiring competitors such as Foyles, Hatchards, and Blackwell's. This trend highlights a growing number of potential UK IPOs, which could reinvigorate the London Stock Exchange and attract more investment into the British economy.
With around 1,800 stores operating across the UK, Boots remains a cornerstone of the high street, and its potential IPO underscores the resilience and adaptability of traditional retail brands in a dynamic market environment.
